Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acidLinda T. Vahdat, RP Jr Warrell, P. Maslak et al.|Blood|1994Cited by 303
The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung CancerAdam J. Schoenfeld, Gregory J. Riely, Yahya Daneshbod et al.|Clinical Cancer Research|2020Cited by 281
Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients With Metastatic <i>EGFR</i>-Mutant Lung CancersHelena A. Yu, Mark G. Kris, Adam J. Schoenfeld et al.|JAMA Oncology|2020Cited by 131
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancerAndrew Chow, Charles M. Rudin, Fathema Uddin et al.|Immunity|2022Cited by 123
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung CancersNoura J. Choudhury, Helena A. Yu, Antonio Marra et al.|Journal of Thoracic Oncology|2022Cited by 95